Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab
Technology
E-136-2018
Patent ID
E-136-2018-1-US-11
Country
US
Application Type
National Stage
Patent Status
Pending
Patent Number
Publication Number
US-2021-0322415-A1
Application Number
16/077,720
IC
NCI
Date Filed
Date Issued
Patent PDF